lactic acid has been researched along with melphalan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Broekmeyer-Reurink, MP; Klaase, JM; Kroon, BB; Nieweg, OE; van de Merwe, SA; van der Zee, J; van Dongen, JA; van Slooten, GW; Vrouenraets, BC | 1 |
| Buurman, WA; De Blaauw, I; de Vries, M; Deutz, NE; Eggermont, AM; Von Meyenfeldt, MF | 1 |
| Beck, K; Haier, J; Hohenberger, P; Schlag, PM | 1 |
| Agrawal, GP; Jain, S; Mishra, AK; Mishra, P; Yadav, AK | 1 |
| Han, MK; Merlin, D; Si, X; Viennois, E; Wang, L; Xiao, B; Zhang, M | 1 |
7 other study(ies) available for lactic acid and melphalan
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physiological implications of hyperbaric oxygen tensions in isolated limb perfusion using melphalan: a pilot study.
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Extremities; Female; Gases; Humans; Hyperbaric Oxygenation; Lactates; Lactic Acid; Male; Melanoma; Melphalan; Middle Aged; Muscles; Oxygen Consumption; Pilot Projects; Sarcoma; Skin | 1996 |
TNF-alpha has no direct in vivo metabolic effect on human muscle.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acids; Ammonia; Antineoplastic Agents, Alkylating; Blood Glucose; Drug Therapy, Combination; Female; Glucose; Humans; Lactic Acid; Male; Melanoma; Melphalan; Middle Aged; Muscle, Skeletal; Sarcoma; Soft Tissue Neoplasms; Tumor Necrosis Factor-alpha | 1997 |
[O2 utilization during hyperthermic extremity perfusion with rhTNF alpha and melphalan].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Carbon Dioxide; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Extremities; Female; Humans; Hyperthermia, Induced; Lactic Acid; Male; Melanoma; Melphalan; Middle Aged; Oxygen; Oxygen Consumption; Reperfusion Injury; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Treatment Outcome; Tumor Necrosis Factor-alpha | 1997 |
Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Topics: Animals; Carcinoma, Ehrlich Tumor; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diffusion; Doxorubicin; Drug Carriers; Hyaluronic Acid; Immunoglobulin G; Lactic Acid; Materials Testing; Melphalan; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Tissue Distribution | 2007 |
Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Topics: Animals; Caco-2 Cells; Camptothecin; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Curcumin; Drug Carriers; Drug Synergism; Humans; Hyaluronic Acid; Immunoglobulin G; Lactic Acid; Male; Melphalan; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2015 |